We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Refined C-Reactive Protein Cutoffs Help Assess Sepsis Risk in Preterm Babies

By LabMedica International staff writers
Posted on 02 Dec 2025

Early-onset sepsis (EOS) is a dangerous bloodstream infection that appears in the first three days of life, yet its early symptoms resemble many benign newborn conditions. More...

To support urgent treatment decisions, clinicians often turn to C-reactive protein (CRP). While CRP is widely used and has a strong negative predictive value, its optimal cutoffs during the first 72 hours of life have been unclear. A multicenter retrospective study now offers a clearer solution by defining time- and gestation-specific CRP thresholds that help identify which newborns—particularly preterm infants—are most likely to have EOS.

In the study conducted at The Chinese University of Hong Kong (Hong Kong SAR), researchers reviewed electronic health records across all public hospitals to evaluate CRP’s diagnostic performance in more than 100,000 newborns over 11 years. The investigators found that CRP rises naturally after birth in healthy babies, peaking around 24 to 32 hours, and this rise is markedly higher in term infants.

Because of this physiological spike, elevated CRP values early in life may not signal infection in term newborns and can lead to unnecessary antibiotic exposure. In contrast, CRP proved far more reliable in preterm infants. A cutoff above 8.0 mg/L after four hours of life identified infection with strong diagnostic performance among babies born before 34 weeks. For early-onset meningitis, a CRP level greater than 12.0 mg/L showed high specificity and strong negative predictive value, helping rule out disease.

The findings emphasize that CRP should not be interpreted using a universal cutoff for all newborns. Instead, clinicians must account for gestational age, timing of sampling, and the expected physiological rise after birth. Used selectively—especially in preterm infants—CRP can provide meaningful support in EOS screening and help guide when to pursue further testing for meningitis.

“Ours is the first population-based study to evaluate how well CRP testing can identify EOS in newborns, highlighting the fluctuations of CRP levels in a real-world setting,” said Prof. Hugh Simon Lam, who led the research team. “Although CRP isn’t a perfect biomarker for EOS detection, it can still help assess infection risk in preterm babies and guide clinicians on whether further testing for meningitis is needed.”

Related Link
The Chinese University of Hong Kong


Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Sample Transportation System
Tempus1800 Necto
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.